Thomas Gallagher

2.5k total citations · 1 hit paper
26 papers, 1.7k citations indexed

About

Thomas Gallagher is a scholar working on Infectious Diseases, Animal Science and Zoology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Thomas Gallagher has authored 26 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 17 papers in Animal Science and Zoology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Thomas Gallagher's work include SARS-CoV-2 and COVID-19 Research (18 papers), Animal Virus Infections Studies (17 papers) and Viral gastroenteritis research and epidemiology (6 papers). Thomas Gallagher is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (18 papers), Animal Virus Infections Studies (17 papers) and Viral gastroenteritis research and epidemiology (6 papers). Thomas Gallagher collaborates with scholars based in United States, Australia and Japan. Thomas Gallagher's co-authors include Michael J. Buchmeier, Stanley Perlman, Edward B. Thorp, Suezanne E. Parker, Hillary L. Logan, Joseph A. Boscarino, Jason Netland, Visweswara Rao Pasupuleti, Roland R. Rueckert and Paul D. Friesen and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Journal of Molecular Biology.

In The Last Decade

Thomas Gallagher

26 papers receiving 1.7k citations

Hit Papers

Coronavirus Spike Proteins in Viral Entry and Pathogenesis 2001 2026 2009 2017 2001 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Gallagher United States 20 1.2k 856 307 249 242 26 1.7k
Ivy Widjaja Netherlands 17 751 0.6× 376 0.4× 282 0.9× 146 0.6× 136 0.6× 21 1.2k
H. Wege Germany 24 1.5k 1.2× 1.5k 1.7× 191 0.6× 368 1.5× 199 0.8× 51 2.0k
Christel Schwegmann‐Weßels Germany 22 956 0.8× 576 0.7× 191 0.6× 292 1.2× 133 0.5× 30 1.3k
Béatrice Nal France 21 1.2k 1.0× 297 0.3× 499 1.6× 118 0.5× 591 2.4× 34 2.1k
Hyun‐Jin Shin South Korea 19 651 0.5× 569 0.7× 152 0.5× 425 1.7× 98 0.4× 93 1.0k
Arno L. W. van Vliet Netherlands 19 553 0.5× 299 0.3× 333 1.1× 156 0.6× 122 0.5× 24 1.1k
Ande West United States 17 1.0k 0.8× 193 0.2× 790 2.6× 248 1.0× 249 1.0× 28 2.0k
Tao Hung China 22 864 0.7× 323 0.4× 354 1.2× 299 1.2× 163 0.7× 62 1.4k
Martin B. Oleksiewicz Denmark 26 1.7k 1.4× 1.8k 2.0× 426 1.4× 1.3k 5.2× 103 0.4× 63 2.6k
Helena J. Maier United Kingdom 18 835 0.7× 515 0.6× 351 1.1× 133 0.5× 195 0.8× 28 1.3k

Countries citing papers authored by Thomas Gallagher

Since Specialization
Citations

This map shows the geographic impact of Thomas Gallagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Gallagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Gallagher more than expected).

Fields of papers citing papers by Thomas Gallagher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Gallagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Gallagher. The network helps show where Thomas Gallagher may publish in the future.

Co-authorship network of co-authors of Thomas Gallagher

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Gallagher. A scholar is included among the top collaborators of Thomas Gallagher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Gallagher. Thomas Gallagher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simon, Neil G., Jim Lagopoulos, Thomas Gallagher, Michel Kliot, & Matthew C. Kiernan. (2015). Peripheral nerve diffusion tensor imaging is reliable and reproducible. Journal of Magnetic Resonance Imaging. 43(4). 962–969. 47 indexed citations
2.
Regla-Nava, José Ángel, Jose M. Jiménez-Guardeño, José L. Nieto-Torres, et al.. (2013). The replication of a mouse adapted SARS-CoV in a mouse cell line stably expressing the murine SARS-CoV receptor mACE2 efficiently induces the expression of proinflammatory cytokines. Journal of Virological Methods. 193(2). 639–646. 13 indexed citations
3.
Zhou, Haixia, Jincun Zhao, Snawar Hussain, et al.. (2010). The N-Terminal Region of Severe Acute Respiratory Syndrome Coronavirus Protein 6 Induces Membrane Rearrangement and Enhances Virus Replication. Journal of Virology. 84(7). 3542–3551. 31 indexed citations
4.
Guo, Ying, Jennifer R. Tisoncik, Susanna McReynolds, et al.. (2009). Identification of a New Region of SARS-CoV S Protein Critical for Viral Entry. Journal of Molecular Biology. 394(4). 600–605. 26 indexed citations
5.
Hussain, Snawar, Stanley Perlman, & Thomas Gallagher. (2008). Severe Acute Respiratory Syndrome Coronavirus Protein 6 Accelerates Murine Hepatitis Virus Infections by More than One Mechanism. Journal of Virology. 82(14). 7212–7222. 27 indexed citations
6.
Boscarino, Joseph A., et al.. (2008). Envelope Protein Palmitoylations Are Crucial for Murine Coronavirus Assembly. Journal of Virology. 82(6). 2989–2999. 92 indexed citations
8.
Pewe, Lecia L., Haixia Zhou, Jason Netland, et al.. (2006). A SARS-CoV–Specific Protein Enhances Virulence of an Attenuated Strain of Mouse Hepatitis Virus. Advances in experimental medicine and biology. 581. 493–498. 5 indexed citations
9.
Thorp, Edward B. & Thomas Gallagher. (2004). Requirements for CEACAMs and Cholesterol during Murine Coronavirus Cell Entry. Journal of Virology. 78(6). 2682–2692. 88 indexed citations
10.
Iijima, Hideki, Markus F. Neurath, Takashi Nagaishi, et al.. (2004). Specific Regulation of T Helper Cell 1–mediated Murine Colitis by CEACAM1. The Journal of Experimental Medicine. 199(4). 471–482. 91 indexed citations
11.
12.
Gallagher, Thomas, et al.. (2002). Quaternary Structure of Coronavirus Spikes in Complex with Carcinoembryonic Antigen-related Cell Adhesion Molecule Cellular Receptors. Journal of Biological Chemistry. 277(22). 19727–19734. 57 indexed citations
13.
Gallagher, Thomas & Michael J. Buchmeier. (2001). Coronavirus Spike Proteins in Viral Entry and Pathogenesis. Virology. 279(2). 371–374. 510 indexed citations breakdown →
14.
Kelly, Sean M., et al.. (2001). Variations in Disparate Regions of the Murine Coronavirus Spike Protein Impact the Initiation of Membrane Fusion. Journal of Virology. 75(6). 2792–2802. 73 indexed citations
15.
Hassanieh, Loubna, et al.. (1999). Mouse Hepatitis Virus Strain JHM Infects a Human Hepatocellular Carcinoma Cell Line. Virology. 264(2). 398–409. 15 indexed citations
16.
Pasupuleti, Visweswara Rao, Suman Kumari, & Thomas Gallagher. (1997). Identification of a Contiguous 6-Residue Determinant in the MHV Receptor That Controls the Level of Virion Binding to Cells. Virology. 229(2). 336–348. 38 indexed citations
17.
Gallagher, Thomas, et al.. (1995). MHVR-Independent Cell-Cell Spread of Mouse Hepatitis Virus Infection Requires Neutral pH Fusion. Advances in experimental medicine and biology. 380. 351–357. 1 indexed citations
18.
Gallagher, Thomas, Michael J. Buchmeier, & Stanley Perlman. (1992). Cell receptor-independent infection by a neurotropic murine coronavirus. Virology. 191(1). 517–522. 74 indexed citations
19.
Gallagher, Thomas & Michael J. Buchmeier. (1990). Monoclonal Antibody-Selected Variants of MHV-4 Contain Substitutions and Deletions in the E2 Spike Glycoprotein. Advances in experimental medicine and biology. 276. 385–393. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026